For the Inventor, By the Inventor

Enter assignee name

Costa Mesa, CA, United States of America

Icn Pharmaceuticals, Inc.

USPTO Granted Patents = 46

Trademarks = 13

Forward Citations = 1,529

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Roland K Robins (14 out of 34 patents)

Robert C Tam (9 out of 21 patents)

Kandasamy Ramasamy (8 out of 11 patents)

4. Guangyi Wang (7 out of 55 patents)

5. Devron R Averett (7 out of 24 patents)

6. Joseph T Witkowski (6 out of 14 patents)

7. Zbigniew Pietrzkowski (4 out of 26 patents)

8. Wilfried E Seifert (3 out of 4 patents)

9. Dariusz Cieslak (3 out of 3 patents)

10. Dennis A Shuman (3 out of 3 patents)

11. Darrell E O'Brien (3 out of 3 patents)

12. Ganapathi R Revankar (3 out of 10 patents)

13. Gordana Olbina (2 out of 2 patents)

14. Joseph Sandor (2 out of 10 patents)

15. Roland K Robins, Deceased (2 out of 3 patents)

Core Competencies:

Monocyclic Nucleosides

Purine Nucleosides

Bicyclic Sugar Moiety

Antisense Oligonucleotides

Cytokine Modulation

Triazole Nucleosides

Xanthine Oxidase Inhibitors

Carbohydrate Conjugates

Ribo-C-Nucleosides

Nitric Oxide Adducts

Tumor Growth Inhibition

Sugar Modified Nucleotides

46 patents: Sort by Forward Citations

1. 6642206 - Monocyclic L-nucleosides, analogs and uses thereof (2003-11-04),

2. 6613896 - Method of producing tiazofurin and other C-nucleosides (2003-09-02),

3. 6573248 - Monocyclic L-nucleosides, analogs and uses thereof (2003-06-03),

4. 6552183 - Moncyclic L-nucleosides analogs (2003-04-22),

5. 6509320 - Purine L-nucleosides, analogs and uses thereof (2003-01-21),

6. 6479463 - Purine L-nucleosides, analogs and uses thereof (2002-11-12),

7. 6403566 - Nucleosides having bicyclic sugar moiety (2002-06-11),

8. 6211201 - Multivalent salts of pyridostigmine and related compounds (2001-04-03),

9. 6191266 - Sugar modified nucleosides (2001-02-20),

10. 6150337 - Specific modulation of Th1/Th2 cytokine expression by Ribavirin in (2000-11-21),

11. 6130326 - Monocyclic L-Nucleosides, analogs and uses thereof (2000-10-10),

12. 6110453 - Polymer-bound nitric oxide/nucleophile adduct compositions, (2000-08-29),

13. 6083482 - Conformationally locked nucleosides and oligonucleotides (2000-07-04),

14. 6063772 - Specific modulation of Th1/Th2 cytokine expression by ribavirin in (2000-05-16),

15. 6017898 - Inhibition of tumor growth by antisense oligonucleotides for IL-8 and (2000-01-25),

ICN Pharmaceuticals, Inc. is a global pharmaceutical company dedicated to improving healthcare through the development, manufacturing, and commercialization of innovative and high-quality pharmaceutical products. With a strong focus on research and development, ICN Pharmaceuticals strives to meet the needs of patients and healthcare professionals across the world. Visit our website to learn more about our company and products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

46 Patents

#7 in Costa Mesa, CA

#1,744 in California

#7,334 in US

#14,689 in the World

Costa Mesa, CA, United States of America

Icn Pharmaceuticals, Inc.

Forward Citations = 1,529

42 inventors:

Roland K Robins (14 out of 34 patents)

Robert C Tam (9 out of 21 patents)

Kandasamy Ramasamy (8 out of 11 patents)

4. Guangyi Wang (7 out of 55 patents)

5. Devron R Averett (7 out of 24 patents)

Please report any incorrect information to support@idiyas.com

Loading…